Zobrazeno 1 - 10 of 65 pro vyhledávání: '"Ribas, Ignacio"'
2
Report
Social Distance Characterization by means of Pedestrian Simulation
Autor: Parisi, Daniel R., Patterson, Germán A., Pagni, Lucio, Osimani, Agustina, Bacigalupo, Tomas, Godfrid, Juan, Bergagna, Federico M., Brizi, Manuel Rodriguez, Momesso, Pedro, Gomez, Fermin L., Lozano, Jimena, Baader, Juan Martin, Ribas, Ignacio, Meyer, Facundo P. Astiz, Di Luca, Miguel, Barrera, Nicolás E., Álvarez, Ezequiel M. Keimel, Oyhanarte, Maite M. Herran, Pingarilho, Pedro R., Zuberbuhler, Ximena, Gorostiaga, Felipe
In the present work, we study how the number of simulated clients (occupancy) affects the social distance in an ideal supermarket. For this, we account for realistic typical dimensions and process time (picking products and checkout). From the simula
Externí odkaz: http://arxiv.org/abs/2009.04019
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with gemcitabine and nab-paclitaxel (GN) in patients with pancreatic adenocarcinoma (PDAC)
Autor: Cutsem, Eric, Eefsen, Rikke Lovendahl, Sebastian Ochsenreither, Zvirbule, Zanete, Ivanauskas, Audrius, Arnold, Dirk, Baltruskeviciene, Edita, Pfeiffer, Per, Yachnin, Jeffrey, Garcia Carbonero, Rocio, Greil, Richard, Jungels, Christiane, Poulsen, Laurids, Awada, Ahmad, Garcia Ribas, Ignacio, Losic, Nedjad, Collignon, Joelle
Publikováno v: Van Cutsem, E, Eefsen, R L, Ochsenreither, S, Zvirbule, Z, Ivanauskas, A, Arnold, D, Baltruskeviciene, E, Pfeiffer, P, Yachnin, J, Garcia Carbonero, R, Greil, R, Jungels, C, Poulsen, L, Awada, A, Garcia Ribas, I, Losic, N & Collignon, J 2022, ' Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with gemcitabine and nab-paclitaxel (GN) in patients with pancreatic adenocarcinoma (PDAC). ', Journal of Clinical Oncology, vol. 40, no. Suppl. 16, pp. 4141 . < https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.4141 >
Web of Science
4141 Background: Interleukin-1 Receptor Accessory Protein (IL1RAP) is expressed on cancer and stromal cells in PDAC. The IL-1 pathway is active in the pancreatic tumor microenvironment and upregulated in response to chemotherapy. IL1RAP interacts wit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bab54ad0b1145eb4e3bda2e7e8f52859
https://vbn.aau.dk/da/publications/41e10015-43bf-4647-9aaa-eb976c04bada
Zobrazit plný text záznamu
5
Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer.:Journal of Clinical Oncology
Autor: Awada, Ahmad, Ochsenreither, Sebastian, Eefsen, Rikke Loevendahl, Arnold, Dirk, Yachnin, Jeffrey, Pfeiffer, Per, Jungels, Christiane, Greil, Richard, Poulsen, Laurids, Van Cutsem, Eric, Thorsson, Lars, Svedman, Christer, Garcia-Ribas, Ignacio, Collignon, Joelle
Publikováno v: Awada, A, Ochsenreither, S, Eefsen, R L, Arnold, D, Yachnin, J, Pfeiffer, P, Jungels, C, Greil, R, Poulsen, L, Van Cutsem, E, Thorsson, L, Svedman, C, Garcia-Ribas, I & Collignon, J 2021, ' Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer. Journal of Clinical Oncology ', Journal of Clinical Oncology, vol. 39, no. Suppl. 15, e16228 . https://doi.org/10.1200/JCO.2021.39.15_suppl.e16228
Awada, A, Ochsenreither, S, Eefsen, R L, Arnold, D, Yachnin, J, Pfeiffer, P, Jungels, C, Greil, R, Poulsen, L, Van Cutsem, E, Thorsson, L, Svedman, C, Garcia-Ribas, I & Collignon, J 2021, ' Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer. Journal of Clinical Oncology ', Journal of Clinical Oncology, vol. 39, no. 15. suppl, e16228 . https://doi.org/10.1200/JCO.2021.39.15_suppl.e16228
e16228Background: Interleukin-1 Receptor Accessory Protein (IL1RAP) is expressed on cancer and stromal cells in many solid tumors. CAN04 is a fully humanized IgG1 targeting IL1RAP blocking IL-1α and ? signaling and triggering ADCC. As monotherapy, C
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7ca218eaa878e85447af075f89d15432
https://portal.findresearcher.sdu.dk/da/publications/92cc03ef-9e7d-4dec-bd62-d28a792af0f6
Zobrazit plný text záznamu
6
Akademický článek
Personal Paper: Gene Therapy for Cancer-Managing Expectations
Autor: Melcher, Alan A., Garcia-Ribas, Ignacio, Vile, Richard G.
Publikováno v: BMJ: British Medical Journal, 1997 Dec . 315(7122), 1604-1607.
Externí odkaz: https://www.jstor.org/stable/25176524
Zobrazit plný text záznamu
8
Projeto e dimensionamento de uma instalação PV dentro de uma micro-rede multi-fontes conectada à rede de distribuição
Autor: Alegre Ribas, Ignacio
Publikováno v: UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Recercat. Dipósit de la Recerca de Catalunya
instname
Este projeto de pesquisa estuda um sistema energético multi-fontes para um consumidor comercial de média tensão (MT). O consumidor objeto deste estudo dispõe já de um gerador diesel que abastece a energia elétrica durante o horário da ponta. A
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cbedd445c4239d43e84b6fb635227742
http://hdl.handle.net/2117/167501
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje